
Sign up to save your podcasts
Or
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
4
1515 ratings
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
39 Listeners
5 Listeners
48 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
3 Listeners
10 Listeners
40 Listeners
7,250 Listeners
14 Listeners
1 Listeners
34 Listeners
0 Listeners
6 Listeners
481 Listeners
12,532 Listeners
3,326 Listeners
3 Listeners
33 Listeners
1,094 Listeners
9,216 Listeners
548 Listeners
133 Listeners
23 Listeners
30 Listeners
363 Listeners
22 Listeners
42 Listeners
2 Listeners
0 Listeners
0 Listeners
0 Listeners